Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Receivables - Other: 2020-2024

Historic Receivables - Other for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $346000.0.

  • Oncology Institute's Receivables - Other fell 530.73% to $339000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $339000.0, marking a year-over-year decrease of 530.73%. This contributed to the annual value of $346000.0 for FY2024, which is 3720.51% down from last year.
  • Oncology Institute's Receivables - Other amounted to $346000.0 in FY2024, which was down 3720.51% from $551000.0 recorded in FY2023.
  • Oncology Institute's Receivables - Other's 5-year high stood at $1.2 million during FY2021, with a 5-year trough of $113000.0 in FY2020.
  • Over the past 5 years, Oncology Institute's median Receivables - Other value was $551000.0 (recorded in 2023), while the average stood at $572800.0.
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 99469.03% in 2021, then tumbled by 5012.13% in 2022.
  • Over the past 5 years, Oncology Institute's Receivables - Other (Annual) stood at $113000.0 in 2020, then skyrocketed by 994.69% to $1.2 million in 2021, then crashed by 50.12% to $617000.0 in 2022, then dropped by 10.7% to $551000.0 in 2023, then tumbled by 37.21% to $346000.0 in 2024.
  • Its last three reported values are $346000.0 in FY2024, $551000.0 for FY2023, and $617000.0 during FY2022.